Sisätautien klinikka

Julkaisut 2012
Publications 2012

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Aalto K et al. Soluble vascular adhesion protein-1 correlates with cardiovascular risk factors and early atherosclerotic manifestations .
2 Abelsson J et al. The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries .
3 Ahola AJ et al. Purchase of antidepressant agents by patients with type 1 diabetes is associated with increased mortality rates in women but not in men.
4 Ahola AJ et al. Sense of coherence, food selection and leisure time physical activity in type 1 diabetes .
5 Ahola TL et al. Adding a low-dose antihypertensive regimen would substantially improve the control of hypertension and reduce cardiovascular morbidity among uncomplicated hypertensive patients.
6 Airaksinen J. Toimenpidekardiologiaa on pystyttävä tarjoamaan yhä useammille potilaille .
7 Airaksinen J et al. Eteiskorvakkeen katetrisulku - uusi vaihtoehto vuotoherkille eteisvärinäpotilaille .
8 Annala AP et al. Long-term safety of drug-eluting stents in patients on warfarin treatment.
9 Bacigelupo A et al. Bone marrow versus peripheral blood as the stem source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups .
10 Baron F et al. Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation .
11 Bhatt DL et al. The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study.
12 Biancari F et al. Benefits and risks of using clopidogrel before coronary artery bypass surgery: Systematic review and meta-analysis of randomized trials and observational studies .
13 Biancari F et al. Estimating the risk of complications related to re-exploration for bleeding after cardiac surgery: a systematic review and meta-analysis .
14 Boraska V et al. Genome-wide meta-analysis of common variant differences between men and women.
15 Bucci M et al. Trimetazidine reduces endogenous free fatty acid oxidation and improves myocardial efficiency in obese humans.
16 Castagno D et al. Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program.
17 Chasman DI et al. Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function.
18 Coviello AD et al. A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple loci implicated in sex steroid hormone regulation .
19 Cwynarski K et al. Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome). A retrospective analysis from the chronic lymphocytic leukemia subcommitee of the chronic leukemia working party and lymphoma working party of the European group for blood and marrow transplantion .
20 Dastani Z et al. Novel Loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: A multi-ethnic meta-analysis of 45,891 individuals.
21 Elovainio M et al. Indoleamine 2,3-dioxygenase activation and depressive symptoms: results from the young Finns study.
22 Elovainio M et al. Socioeconomic status and the development of depressive symptoms from childhood to adulthood: A longitudial analysis across 27 years of follow-up in the Young Finns study .
23 Estrada K et al. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture .
24 Fagerholm E et al. SNP in the genome-wide association study hotspot on chromosome 9p21 confers susceptibility to diabetic nephropathy in type 1 diabetes .
25 Finckenberg P et al. Caloric restriction ameliorates angiotensin II-induced mitochondrial remodeling and cardiac hypertrophy.
26 Finke J et al. Prognostic factors affecting outcome after allogeneic transplantation for hematologial malignancies form unrelated donors: Results from a randomized trial .
27 Firtser S et al. Relation of total and free testosterone and sex hormone-binding globulin with cardiovascular risk factors in men aged 24-45 years. The cardiovascular risk in young Finns study. .
28 Gaemperli O et al. Cardiac hybrid imaging.
29 Gaál EI et al. Intracranial aneurysm risk locus 5q23.2 is associated with elevated systolic blood pressure.
30 George RT et al. Myocardial perfusion by CT versus hybrid imaging.
31 Gheorghiade M et al. Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes.
32 Goodman SG et al. Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial.
33 Gruber FX et al. BCR-ABL isoforms associated with intrinsic or acquired resistance to imatinib: more heterogeneous than just ABL kinase domain point mutations?
34 Gunn J et al. Comparison of results of coronary artery bypass grafting versus percutaneous coronary intervention in octogenarians .
35 Haarala A et al. Relation of high cytomegalovirus antibody titres to blood pressure and brachial artery flow-mediated dilation in young men: the Cardiovasucular Risk in Young Finns Study .
36 Hakala M et al. Once-monthly oral ibandronate provides significant improvement in bone mineral density in postmenopausal women treated with glucocorticoids for inflammatory rheumatic diseases: a 12-month, randomized, double-blind, placebo-controlled trial.
37 Hartiala O et al. Adolescence risk factors are predictive of coronary artery calcification at middle age: the cardiovascular risk in young Finns study.
38 Hartz SM et al. Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers .
39 Healey JS et al. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin .
40 Heinonen I et al. Regulation of subcutaneous adipose tissue blood flow during exercise in humans .
41 Heinonen I et al. Effects of adenosine, exercise, and moderate acute hypoxia on energy substrate utilization of human skeletal muscle .
42 Heiro M , Koskinen P. Elinsiirtopotilas perusterveydenhuollossa .
43 Hernesniemi J et al. Genetic profiling using genome-wide significant coronary artery disease risk variants does not improve the prediction of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study, the Bogalusa Heart Study and the Health 2000 Survey.
44 Hietala K et al. The risk of proliferative retinopathy in siblings with type 1 diabetes .
45 Hietalampi H et al. Left ventricular mass and geometry in adolescence. Early childhood determinants.
46 Hyvönen ME et al. INPPL1 is associated with the metabolic syndrome in men with type 1 diabetes, but not with diabetic nephropathy.
47 Hänninen MR et al. Prognostic significance of masked and white-coat hypertension in the general population: the Finn-Home Study .
48 Härkönen R et al. Munuaisten ja virtsateiden isotooppitutkimukset.
49 Iida H et al. F-18 fluorodeoxyglucose uptake and water-perfusable tissue fraction in assessment of myocardial viability .
50 Inouye M et al. Novel loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis .
51 Iozzo P et al. The interaction of blood flow, insulin, and bradykinin in regulating glucose uptake in lower-body adipose tissue in lean and obese subjects.
52 Jaakkola U et al. Neuropeptide Y polymorphism increases the risk for asthma in overweight subjects; protection from atherosclerosis in asthmatic subjects - The cardiovascular risk in young Finns study.
53 Johansson JK et al. Prognostic value of the variability in home-measured blood pressure and heart rate: the Finn-Home study.
54 Jokela M et al. Body mass index and depressive symptoms: instrumental-variables regression with genetic risk score.
55 Joutsiniemi E et al. Resting coronary flow velocity in the functional evaluation of coronary artery stenosis: study on sequential use of computed tomography angiography and transthoracic Doppler echocardiography .
56 Juhola J et al. Childhood physical, environmental, and genetic predictors of adult hypertension. The cardiovascular risk in young Finns study.
57 Juonala M. Passiivinen tupakointi valtimokovettumataudin riskitekijänä.
58 Juonala M et al. Parental smoking in childhood and brachial artery flow-mediated dilatation in young adults. The cardiovascular risk in young Finns study and the childhood determinants of adult health study.
59 Juonala M et al. Lapsuuden elintavat vaikuttavat valtimotaudin kehittymiseen.
60 Jylhävä J et al. A genome-wide association study identifies UGT1A1 as a regulator of serum cell-free DNA in young adults: The cardiovascular risk in young Finns study.
61 Jyrkkiö S et al. Syöpäpotilaan suun hoidon erityispiirteet .
62 Jääskeläinen P et al. Childhood nutrition in predicting metabolic syndrome in adults. The Cardiovascular Risk in Young Finns Study .
63 Kaikkonen JE et al. Childhood serum cholesterol ester fatty acids are associated with blood pressure 27 y later in the Cardiovascular Risk in Young Finns Study .
64 Kainulainen K et al. Hyönteisten välittämiä ja muita infektiotauteja.
65 Kajander S et al. Sepelvaltimoiden TT-kuvaus: Tekniikka, käyttöaiheet ja rajoitukset .
66 Kantola I et al. Fabryn tauti.
67 Kappert K et al. Impact of sex on cardiovascular outcome in patients at high cardiovascular risk. Analysis of the Telmisartan Randomized Assessment Study in ACE-intolerant Subjects with Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Combination with Ramipril Global End Point Trial (ONTARGET).
68 Karjalainen PP et al. A prospective randomised comparison of titanium-nitride-oxide-coated bioactive stents with everolimus-eluting stents in acute coronary syndrome: the BASE-ACS trial .
69 Kestilä P et al. Socioeconomic status, cardiovascular risk factors, and subclinical atherosclerosis in young adults. The cardiovascular risk in young Finns study .
70 Kettunen J et al. Genome-wide association study identifies multiple loci influencing human serum metabolite levels .
71 Kiviniemi T et al. Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention .
72 Kiviniemi TO et al. Pravastatin-induced improvement in coronary reactivity and circulating ATP and ADP levels in young adults with type 1 diabetes.
73 Knuuti J , Saraste A. Advances in clinical application of quantitative myocardial perfusion imaging .
74 Knuuti J et al. Non-invasive imaging for coronary disease.
75 Koivikko ML et al. Autonomic cardiac regulation during spontaneous nocturnal hypoglycemia in patients with type 1 diabetes .
76 Koivistoinen T et al. Arterial pulse wave velocity in relation to carotid intima-media thickness, brachial flow-mediated dilation and carotid artery distensibility: the Cardiovascular Risk in Young Finns Study and the Health 2000 Survey.
77 Koivuviita N et al. The effect of revascularization of renal artery stenosis on renal perfusion in patients with atherosclerotic renovascular disease.
78 Korhonen P et al. Assessment of cardiovascular risk in primary health care .
79 Korhonen PE et al. Estimating glomerular filtration rate in hypertensive subjects: Comparison of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study equations.
80 Koskinen J et al. Association of liver enzymes with metabolic syndrome and carotid atherosclerosis in young adults. The Cardiovascular Risk in Young Finns Study. .
81 Koskinen J et al. Effect of age, gender and cardiovascular risk factors on carotid distensibility during 6-year follow-up. The cardiovascular risk in Young Finns study.
82 Koskinen J et al. Apolipoprotein B, oxidized low-density lipoprotein, and LDL particle size in predicting the incidence of metabolic syndrome: the Cardiovascular Risk in Young Finns study.
83 Kozakova M et al. Fatty liver index, gamma-glutamyltransferase, and early carotid plaques.
84 Kristiansson K et al. Genome-wide screen for metabolic syndrome susceptibility loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits.
85 Kuparinen T et al. Genome-wide association study does not reveal major genetic determinants for anti-cytomegalovirus antibody response .
86 Lahtela H et al. Heparin bridging vs. uninterrupted oral anticoagulation in patients with atrial fibrillation undergoing coronary artery stenting .
87 Laitinen TT et al. Ideal cardiovascular health in childhood and cardiometabolic outcomes in adulthood: The cardiovascular risk in young Finns study .
88 Lammintausta A et al. Socioeconomic inequalities in the morbidity and mortality of acute coronary events in Finland: 1988 to 2002.
89 Landsvig Berentzen T et al. Waist circumference adjusted for body massa index and intra-abdominal fat mass .
90 Lankinen P et al. A comparative 18F-FDG PET/CT imaging of experimental staphylococcus aureus osteomyelitis and staphylococcus epidermidis foreign-body-associated infection in the rabbit tibia.
91 Lauhio A et al. Serum matrix metalloproteinase-8 and -9 levels in disseminated Lyme Borreliosis with special reference to artritis .
92 Lehtinen T et al. Stent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study.
93 Lehtinen T et al. Early vascular healing after endothelial progenitor cell capturing stent implantation .
94 Lehto H-R et al. Effects of acute and one-week fatty acid lowering on cardiac function and insulin sensitivity in relation with myocardial and muscle fat and adiponectin levels.
95 Lehtopolku M et al. Inaccuracy of the disk diffusion method compared with the agar dilution method for susceptibility testing of Campylobacter spp.
96 Leirisalo-Repo M et al. Reumatologipula kriisiyttää erikoisalan.
97 Lindström V et al. Indoleamine 2,3-dioxygenase activity and expression in patients with chronic lymphocytic leukemia .
98 Lund J et al. Percutaneous left atrial appendage closure with minimal antithrombotic treatment in patients at very high risk of bleeding events.
99 Lähteelä K et al. No association of nineteen COX-2 gene variants to preclinical markers of atherosclerosis The Cardiovascular Risk in Young Finns Study.
100 Magnussen CG et al. A diagnosis of the metabolic syndrome in youth that resolves by adult life is associated with a normalization of high carotid intima-media thickness and type 2 diabetes mellitus risk: the bogalusa heart and cardiovascular risk in young Finns studies.
101 Magnussen CG et al. When and how to start prevention of atherosclerosis? Lessons from the Cardiovascular Risk in the Young Finns Study and the Special Turku Coronary Risk Factor Intervention Project.
102 Malmberg M. Clinical and experimental studies on cardiomyocyte apoptosis in ischemia-reperfusion injury and myocardial protection during cardiac surgery.
103 Malmberg M et al. Intracoronary levosimendan during ischemia prevents myocardial apoptosis.
104 Mansikkaniemi K et al. Cross-sectional associations between physical activity and selected coronary heart disease risk factors in young adults. The Cardiovascular Risk in Young Finns Study.
105 Masi S et al. Similar patterns of myocardial metabolism and perfusion in patients with type 2 diabetes and heart disease of ischaemic and non-ischaemic origin.
106 Mattila E et al. Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection .
107 Mattsson N. Metabolic syndrome in young adults. Prevalence, childhood predictors and association with subclinical atherosclerosis. The Cardiocascular Risk in Young Finns Study.
108 McQuillan R et al. Evidence of inbreeding depression on human height .
109 Mehta SR et al. Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation .
110 Mercier N et al. Impaired ATP-induced coronary blood flow and diminished aortic NTPDase activity precede lesion formation in apolipoprotein E-deficient mice .
111 Merjonen P et al. Moderation of breastfeeding effects on adult depression by estrogen receptor gene polymorphism.
112 Mikkola R et al. Use of blood products and risk of stroke after coronary artery bypass surgery .
113 Mikkola R et al. Timing of preoperative aspirin discontinuation and outcome after elective coronary artery bypass graft surgery .
114 Morrow DA et al. Vorapaxar in the secondary prevention of atherothromboic events.
115 Mäki MT et al. Cardiac function, perfusion, metabolism, and innervation following autologous stem cell therapy for acute ST-elevation myocardial infarction. A FINCELL-INSIGHT sub-study with PET and MRI .
116 Mäkinen V-P et al. Sphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study).
117 Nelimarkka L, Arola OJ. Ketoasidoosin hoito.
118 Niinikoski H et al. Effect of repeated dietary counseling on serum lipoproteins from infancy to adulthood .
119 Niiranen TJ et al. The International Database of HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO): moving from baseline characteristics to research perspectives.
120 Nummenmaa L et al. Dorsal striatum and its limbic connectivity mediate abnormal anticipatory reward processing in obesity.
121 Oikonen M et al. Associations between serum uric acid and markers of subclinical atherosclerosis in young adults. The cardiovascular risk in Young Finns study.
122 Oikonen M et al. Tissue inhibitor of matrix metalloproteinases 4 (TIMP4) in a population of young adults: Relations to cardiovascular risk markers and carotid artery intima-media thickness. The Cardiovascular Risk in Young Finns Study.
123 Okada Y et al. Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations.
124 Passweg JR et al. The EBMT activity survey: 1990-2010.
125 Pattaro C et al. Genome-wide association and functional follow-up reveals new Loci for kidney function .
126 Pietilä M. Mitä sinä haluat Lääkäriliitolta?
127 Pietilä M. Muutoksessa on pysyttävä mukana.
128 Pietilä M et al. Raskaudenaikainen sydäninfarkti - hoidollinen haaste .
129 Porela P et al. PR depression is useful in the differential diagnosis of myopericarditis and ST elevation myocardial infarction .
130 Raiko JRH et al. Plasminogen activator inhitor-1 associates with cardiovascular risk factors in healthy young adults in the Cardiovascular Risk in Young Finns Study.
131 Ramasamy A et al. Genome-wide association studies of asthma in population-based cohorts confirm known and suggested loci and identify an additional association near HLA.
132 Rantalaiho V et al. Long-term results of the FIN-RACo trial; treatment with a combination of traditional disease-modifying anti-rheumatic drugs is an excellent option in early rheumatoid arthritis .
133 Rausova Z et al. System approach to modeling of liver glucose metabolism with physiologically interpreted model paraments outgoing from [18 F] concentrations measured by PET.
134 Redon J et al. Safety and efficacy of low blood pressures among patients with diabetes .
135 Ristiniemi N et al. Cystatin C as a predictor of all-cause mortality and myocardial infarction in patients with non-ST-elevation acute coronary syndrome .
136 Rosenström T et al. Associations between dimensional personality measures and preclinical atherosclerosis: The cardiovascular risk in young Finns study.
137 Rosenström T et al. Pairwise measures of causal direction in the epidemiology of sleep problems and depression.
138 Rubboli A et al. The management of patients on oral anticoagulation undergoing coronary stent implantation: A survey among interventional cardiologists from eight European countries .
139 Ruff CT et al. Safety and efficacy of prasugrel compared with clopidogrel in different regions of the world .
140 Salmenniemi U, Remes K. Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma .
141 Saraste A et al. PET: Is myocardial flow quantification a clinical reality?
142 Saraste A et al. Reply to letter to the editor (JNC-12-15-LE) regarding "PET: Is myocardial flow quantification a clinical reality? .
143 Saraste A, Knuuti J. Cardiac PET, CT, and MR: what are the advantages of hybrid imaging?
144 Saraste A, Knuuti J . Perfuusio- ja hybridikuvantaminen .
145 Saraste A, Knuuti J. Novel CT-based imaging markers for high-risk coronary plaques .
146 Saraste A et al. Sydämen kuvantaminen . Esipuhe.
147 Saraste A et al. Diet intervention reduces uptake of alfavbeta3 intergrin-targeted PET tracer 18F-galacto-RGD in mouse atherosclerotic plaques.
148 Scirica BM et al. Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2omicronP-TIMI 50 trial .
149 Service SK et al. A genome-wide meta-analysis of association studies of Cloninger's Temperament Scales.
150 Sinner MF et al. A meta-analysis of genome-wide association studies of the electrocardiographic early repolarization pattern.
151 Sipilä K et al. Carotid artery intima-media thickness and elasticity in relation to glucose tolerance.
152 Soro-Paavonen A et al. Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications.
153 Spyridonidis A et al. Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT.
154 Stark C et al. Therapeutic potential of thymosin ß4 in myocardial infarct and heart failure.
155 Sundell J. Vähähiilihydraattinen ruokavalio eli ns. karppaus.
156 Sundell J. Hanki lihasta, polta rasvaa.
157 Sundell J. Ravintolisät terveillä - hyötyä vai haittaa? .
158 Sundell J et al. Both BMI and waist circumference are associated with coronary vasoreactivity in overweight and obese men .
159 Suomela JP et al. Children's hedonic response to berry products: Effect of chemical composition of berries and hTAS2R38 genotype on liking .
160 Söderlund J et al. HLA class II is a factor in cardiovascular morbidity and mortality rates in patients with type 1 diabetes.
161 Tarkia M et al. Evaluation of 68Ga-labeled tracers for PET imaging of myocardial perfusion in pigs.
162 Thomas MC et al. Hyperfiltration in type 1 diabetes: does it exist and does it matter for nephropathy? .
163 Toivonen R et al. Intracardiac injection of a capsid-modified Ad5/35 results in decreased heart toxicity when compared to standard Ad5.
164 Tricoci P et al. Thrombin-receptor antagonist vorapaxar i n acute coronary syndromes .
165 Tukiainen T et al. Detailed metabolic and genetic characterization reveals new associations for 30 known lipid loci .
166 Tuomainen PO et al. Gender-based analysis of the 3-year outcome of bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: An insight from the TITAX-AMI trial .
167 Tuominen L et al. Temperament trait harm avoidance associates with my-opioid receptor availability in frontal cortex: A PET study using [11 C] carfentanil .
168 Tuominen R et al. Consistency of assessments and willingness to pay for a reduction in morning symptoms over time in patients with rheumatoid arthritis.
169 Ukkonen H , Koskenvuo J . Iskeemisen kardiomyopatian kuvantaminen .
170 Uusi-Rasi K et al. Overweight in childhood and bone density and size in adulthood .
171 Vaara ST et al. Fluid overload is associated with an increased risk for 90-day mortality in critically ill patients with renal replacement therapy: data from the prospective FINNAKI study.
172 Vardeny O et al. Influence of diabetes on efficacy of aliskiren, losartan or both on left ventricular mass regression.
173 Varis J, Kantola I. Quantification of adherence initiatives results.
174 Verdecchia P et al. Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk .
175 Verweij KJ et al. Maintenance of genetic variation in human personality: Testing evolutionary models by estimating heritability due to common causal variants and investigating the effect of distant inbreeding .
176 Virtanen JM et al. The relationship between cardiac and liver iron evaluated by MR imaging in haematological malignancies and chronic liver disease .
177 Wessman J et al. Temperament clusters in a normal population: Implications for health and disease .
178 Williams WW et al. Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy .
179 Wu J et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human .
180 Würtz P et al. Metabolic signatures of insulin resistance in 7,098 young adults .
181 Würtz P et al. High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis.
182 Yang X et al. Moderating effects of leisure-time physical activity on the association between job strain and depressive symptoms: The cardiovascular risk in young Finns study .
183 Ylitalo A et al. Invasiivinen kuvantaminen stenoosin arvioinnissa.
184 Ylitalo A et al. Sepelvaltimoahtauman arviointi kajoavilla menetelmillä .
185 Zheng H-F et al. WNT16 influences bone mineral density, cortical bone thickness, bone strenght, and osteoporotic fracture risk .
Julkaisutietokanta 3.9.2013 Publications Data Base 3.9.2013